These new leaders will guide our strategic goals and help ensure every individual affected by cancer has a hematology/oncology pharmacist as an integral member of their care team.

All terms begin at the Annual Conference, April 13-17, 2021.


Heidi D. Finnes, PharmD, BCOP, FHOPA Heidi D. Finnes, PharmD, BCOP, FHOPA

Current Employment
Senior Manager of Pharmacy Cancer Research and Director of the Pharmacy Shared Resource | Mayo Clinic Cancer Center

Assistant Professor of Pharmacy | Mayo Clinic College of Medicine

Election Statement

My name is Heidi Finnes, PharmD, BCOP, FHOPA and I am proud to be a candidate for President-Elect. I am the Senior Manager of Pharmacy Cancer Research and Director of the Pharmacy Shared Resource at Mayo Clinic, Rochester, MN. I am an Assistant Professor of Pharmacy and have been a proud Mayo Clinic employee for 22 years. I have been a HOPA member since 2004 and was an At-Large Board member from 2015-2019. I have been a member of the Annual Conference, Tools and Resources and Quality Committees. I was chair of the Annual Conference Committee, Session Proposal Subcommittee, and Time to Talk Immuno-Oncology Task Force.

Recently, I helped facilitate the Investigational Drug Service (IDS) Special Interest Group to become active in establishing best practices post-COVID-19. As President-Elect, I will advocate for HOPA to see COVID-19 challenges as opportunities for pharmacists. The healthcare paradigm has shifted to bring cancer care to the patient. Pharmacist provider status and oral chemotherapy parity must be realized during our tenure to expand access to healthcare. I will work with you to create bold, innovative pharmacy services in hospital, clinic, specialty, IDS and community pharmacy settings.

I support research on telehealth and quality metrics that highlight the vital role pharmacists play in cancer care. We must promote “Pharmacist Phorward” practice ideas to facilitate mentorship opportunities and create collaborations with outside organizations. Together, we can shape the future of oncology pharmacy. I would be honored to pursue these goals with you as President-Elect. Thank you for your consideration.


Amber P. Lawson, PharmD, BCOP Amber P. Lawson, PharmD, BCOP

Current Employment
Program Coordinator | University of Kentucky HealthCare

Election Statement

It is an honor to be nominated for the Secretary position of the HOPA Board of Directors. I have been a member of HOPA for nearly 15 years and have served in various roles including the Nominations Subcommittee (Vice Chair/Chair), Governance Committee, Research Council, and Quality Oversight Committee. Throughout my career, I have had the opportunity to lead and support clinical teams, precept pharmacy student and resident learners, oversee high-impact clinical and administrative initiatives, evaluate research protocols and data safety monitoring at the Cancer Center level, and coordinate hematology/oncology formulary management. These experiences have given me a broad exposure and appreciation for the many important roles the hematology/oncology pharmacy department serves within the healthcare system.

Over time, we have witnessed the ever-increasing complexity of cancer care require hematology/oncology pharmacists and technicians to evolve their practices in order to meet patient needs. Through the expertise of its membership, HOPA provides the infrastructure to elevate and adapt our professional contributions to the changing healthcare landscape through the goals and objectives outlined within the strategic plan. If elected, I will work with the Board of Directors and membership to anticipate and evaluate opportunities and challenges that face us as we seek to advance our profession. It is important to build on existing relationships with other stakeholders and clearly communicate what HOPA offers our patients and our profession. I humbly ask for your vote in order to have the opportunity to represent the membership and advance the organization’s vision as we look forward.

At-Large Member

Andrea Iannucci, PharmD, BCOPAndrea Iannucci, PharmD, BCOP

Current Employment
Assistant Chief Pharmacist; Oncology, and Investigational Drugs Oncology Clinical Pharmacy Specialist, Residency Director, PGY2 Oncology Specialty Residency | UC Davis Medical Center

Health Science Clinical Professor (WOS) | UC San Francisco; School of Pharmacy

Volunteer Clinical Professor | UC Davis; School of Medicine

Election Statement

I've been an oncology pharmacist for over 25 years and a HOPA member since 2005. I have benefitted from the professional development, committee activities and networking offered by HOPA. I have long admired HOPA's commitment to supporting the advancement of pharmacy practitioners and their vision to ensure that every person with cancer has an oncology pharmacist on their team, advocating for them and optimizing their care. I think pharmacy has struggled, as a profession, to get the public to understand the importance of their role in patient care. However, HOPA is on a path to improve that through the initiatives outlined in their strategic plan and I would like to participate in those efforts.

If selected as a member of the HOPA Board of Directors, I would work with HOPA to achieve their strategic goals and develop a platform for pharmacists to be recognized more readily as pivotal members of the healthcare team. I think this can be achieved through collaboration with other oncology and pharmacy organizations on important safety, quality and access-to-care initiatives, as well as through engaging patients, who have been impacted by oncology pharmacists, to share their experiences in a public venue. Having benefitted both personally and professionally as a HOPA member for so many years, it would be a privilege to serve HOPA as an At-Large Member of the Board of Directors.


Thank you, HOPA Members, for casting your ballot in the 2021 Board of Elections!